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ABSTRACT
Evaluating the Impacts of Vaccination, Antiviral Treatment and
School Closure on Influenza Epidemic
Xiaofei Shi
Multi-objective simulation optimization was performed to investigate the cost and
benefits of the most commonly-used strategies for H1N1 epidemic mitigation: vaccination,
antiviral treatment, and school closure. By simultaneously considering three intervention
strategies, this study leads to findings that supplement those in the existing work, and
provides additional insights regarding intervention decision making. Specifically, our inves-
tigation suggests that different vaccine prioritization strategies, the age-based versus ACIP
recommendation, be implemented depending on vaccine availability; individual school clo-
sure policies are favored over their global counterparts, at least when both vaccination and
antiviral treatment are implemented with relatively plentiful medicine supply. The trade-
offs of cost and benefits of the intervention strategies were investigated, and can be used to
support relevant decision making.
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Chapter 1
Introduction
Influenza is a serious public health problem that causes severe illness and death in
high risk populations. To prevent an epidemic, a wide range of mitigation strategies have
been investigated including vaccine allocation, use of antiviral, school closure policies, etc.
In the current literature, agent-based simulation models (ABM) have been developed and
served as an effective and popular method to investigate the mitigation effects of different
intervention policies [1, 2, 3, 4]. However, the existing work is typically restricted to a small
set of decision variables concerning a certain intervention aspect. For instance, Lee et al[3]
compared the impacts of different vaccine prioritization policies when vaccine is in limited
supply; Brown et al[4] evaluated various school closure policies specified by different closure
lengths. These work focused on limited scenarios generated by varying one or two selected
decision variables, evaluated those scenarios through ABM, and derived insights as to the
main effects of the selected variables. Hence, they do not allow for the investigation of
the potential interacting effects of mitigation policies (for example, the interacting effects
of vaccine prioritization policies and the vaccine supply quantity), and neither are they
adequate for the exploration of optimal policies concerning a range of mitigation strategies.
In light of the discussions above, an effort was made in this thesis to simultaneously
consider a large number of decision variables that specify three intervention aspects: vac-
cination, antiviral treatment, and school closure policies. The stochastic ABM developed
through the Models of Infectious Disease Agent Study (University of Pittsburgh MIDAS
National Center of Excellence 2009) was adopted as the scenario evaluation tool for H1N1.
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The ABM has been extended in this work to track a range of performance metrics including
attack/death rate of the disease, infections, years of life lost, productivity losses, and the
total cost incurred. Clearly, there are trade-offs between the intervention benefits and costs.
To explore the solutions in the large decision space while balancing the benefits and
costs of invention strategies, we adapted a genetic algorithm (GA)-based multi-objective sim-
ulation optimization method. The Pareto frontier of the non-dominated solutions obtained
was further investigated, and used to derive interesting insights regarding the intervention
policies.
2
Chapter 2
Methods
2.1 Agent-Based Simulation Model
A large population and dynamic individuals network are usually required for studies of infec-
tions diseases, such as influenza. In previous studies, there have been two main approaches
used to understand the spread of infection diseases: theoretical approach and experimental
approach. However, when dealing with a large population and the dynamic individuals net-
work among this population, these two approaches may have limitations. The system would
be too complex to be mapped by analytical expressions or experiments, or the extensive
computation time would be too expensive to build such experiments[5]. In recent years,
a computational approach,which is called an agent-based model(ABM), is becoming more
commonly used. This model is a rule-based, discrete-time, discrete-event computational
modelling methodology for simulating the actions of agents that interact within an environ-
ment and other agents. Rule-based means using rules to make decisions; discrete-time means
measuring variables of interest at each separate time step; discrete-event means a discrete
sequence of events, each event occurs at a certain time period and makes a change to the
system[6]. An agent-based model would provide explanatory insight into the actions and
interactions of agents under certain rules in discrete time periods with a discrete sequence
of events.
In this work, the ABM simulates the H1N1 influenza spread within Allegheny County,
Pennsylvania, with a population of 1,164,779 individuals, 524,584 households, 532 schools,
and 48,703 work places. Based on the data from H1N1 2009 influenza epidemic in the U.S.
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(2009-2010), the reproductive rate of H1N1 is set as 1.8[7], and the simulation length is set
as 180 days to reflect the length of the epidemic season[8].
2.2 The FRED Framework
FRED, the stochastic ABM available at the website of Framework for Reconstructing Epi-
demiological Dynamics (University of Pittsburgh Public Health Dynamics Laboratory 2013),
was used in this simulation study. This ABM includes explicit representations of the county’s
population with each agent (virtual person) possessing a set of sociodemographic character-
istics and daily behaviors; provides a range of parameters to characterize a disease (e.g., the
basic reproductive rate); and has a range of built-in actions for epidemic mitigation.[9]
FRED has more than 400 parameters.The definition of most parameters can be found
in FRED User Guide[9]. Most of the input parameters can be divided into three cate-
gories: natural history parameters, transmission parameters, and health related behaviors.
There are also several main sets of intervention parameters: the school closure intervention
strategies, vaccination intervention strategies, and antiviral treatment strategies. The model
outputs include fatality rate, symptomatic incidence, attack rate, reproductive ratio, etc.
The FRED simulation model can be used to estimate the effect, cost, and efficiency of each
intervention strategies and compare them for an influenza pandemic.
In the beginning of the simulation, FRED sets up the initial environment and assigns
to each agent a range of properties. Each agent represents an individual living within the
area considered. These properties include
• demographic information (e.g., age, gender etc.);
• health information (e.g., current health status, immunization, infectiousness etc.);
• location of social activity (e.g., household, neighborhood, school or workplace etc.);
and
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• health-related behaviors (e.g., contact rate at different locations, probability of staying
home when sick, probability of getting a vaccine etc.)
After initializing the environment and population, FRED inserts some number of infected
cases into the population randomly. As the simulation proceeds, each agent will perform
his daily activities. For instance, students will go to school, adults to work, and patients
to hospital. Through these activities, a healthy agent may get infected when contacting an
infected agent. A patient may be cured after accepting an antiviral treatment. At the end
of a day, the property of agents will be updated and get ready for the next-day simulation.
This circle is repeated until the last day of simulation period.
2.3 Genetic Algorithm
Genetic Algorithm is a heuristic search algorithm that mimics the process of natural selection,
a biological process in which stronger individuals are likely be the winners in a competing
environment. The potential solution of a problem is assumed as an individual and can be
represented by a set of parameters, which are regarded as the genes of a chromosome and
can be structured by a string of values in binary form. The fitness value is used to reflect
the degree of goodness of the chromosome for solving the problem, and this value is closely
related to its objective value.
In each cycle of genetic operation, the genes of the parents are to be mixed and
recombined to produce the offspring in the next generation. It is expected that from this
process of evolution, the chromosome with higher fitness will create a large number of off-
spring, and thus has a higher chance of surviving in the subsequent generation, such as
the survival-of-the-fittest mechanism in nature. Throughout the evolving process, the fitter
chromosome has the tendency to yield good-quality offspring, which means a better solution
to the problem.[10]
A general GA process usually includes the following steps: initialization, selection,
genetic operators and termination. For a given problem, the chromosomes are coded to
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represent each possible solution. The initial population is generated randomly. Several
parameters such as population size and mutation rate are set to process the evolving cycle.
To generate good offspring, a proficient parent selection mechanism is necessary. This
is a process used to determine the number of trials for one particular individual used in
reproduction.
The genetic operators include crossover operator and mutation operator. In this
process, a new offspring is created which typically shares many of the characteristics of its
parents using the above methods of crossover and mutation. These processes ultimately
result in the next generation population of chromosomes that is different from the previ-
ous generation. Generally the average fitness will have increased by this procedure for the
population.
The evolving cycle is repeated until a termination condition has been reached. For
example: the fixed number of max generations is reached or a solution is found which satisfies
minimum criteria.
2.4 Intervention Strategies and Decision Variables
Figure 2.1 provides an overview of the intervention strategies considered in this work. A
total of 15 decision variables are used to define the vaccine, antiviral and school closure
policies, and to specify a scenario of the combination strategies. As detailed in the rest of
this subsection, a range of experimental values are selected for each variable to investigate the
variable’s quantitative impacts, which leads to 10,459,400 alternative policy combinations.
2.4.1 Vaccines
Vaccination is the principal preventive strategy to prevent an outbreak of influenza epidemic
and to reduce the disease burden of infectious diseases. Large quantities of vaccines are
produced and distributed all over the world to prevent the outbreak of influenza such as
H1N1 and H5N1. How do the vaccine availability and prioritization affect the effectiveness
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Figure 2.1: The Intervention Strategies and Decision Variables.
of vaccination to mitigate an influenza epidemic? The vaccination plan and policies are
specified by seven variables (V1)-(V7) in this work.
(V1) enable vaccination: It is a Boolean variable, which can be either 0 or 1. A value
of 0 corresponds to no implementation of vaccination strategies at all; and when (V1) is
equal to 0, the variables (V2)-(V7) play no part in the simulation model. When (V1) takes
a value of 1, the variables (V2)-(V7) come into play and their settings specify a vaccination
plan to be implemented.
(V2) vaccine prioritize acip and (V3) vaccine prioritize by age: The variable pair (V2,
V3) is a two-digit Boolean vector, which could be either (1, 0) or (0, 1) corresponding to
different types of vaccine prioritization policies detailed as follows.
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• If (V2, V3) is set as (1, 0), then the ACIP vaccine prioritization policy is adopted.
ACIP refers to the vaccine prioritization recommended by the Advisory Committee
on Immunization Practices (ACIP) on July 29, 2009. By adopting the ACIP, the fol-
lowing groups of people have higher priority to receive the influenza vaccine [3]: preg-
nant women, household contacts and caregivers for children younger than 6 months of
age, healthcare and emergency medical services personnel, all people from 6 months
through 24 years of age, and persons aged 25 through 64 years who have health condi-
tions associated with higher risk of medical complications from influenza. The ACIP
recommendation is primarily based on occupational risk of vulnerable populations.
• If (V2, V3) is set as (0, 1), then the age-based prioritization policy is employed. The
age-based policy requires dividing the population into several age groups. In this work,
five age groups[11] are considered: (i) 0-5 years of age, (ii) 6-24 years of age, (iii) 25-44
years of age, (iv) 45-64 years of age, and (v) 65 years old and above. An age-based
policy is defined by a selected age group with priority over other groups, and the
selected group is specified by the variable pair (V4, V5) as below.
(V4) vaccine priority age low and (V5) vaccine priority age high: These two variables
(V4, V5) specify the lower and upper bounds of the priority age group. Based on the five
age groups (i)-(v) considered, (V4, V5) can take values (0, 5), (6, 24), (25, 44), (45, 64) and
(65, 120) assuming that 120 is the highest possible age.
(V6) vaccine total avail: It is the total amount of vaccine that will be made avail-
able during the influenza season. Timely production and delivery of sufficient vaccine still
remains a challenge, and variable (V6) constrains the maximum number of people that can
be vaccinated. According to Fedson[12], the doses of influenza vaccine distributed in North
America is about 26.5% of the population. Thus, in our exploration, (V6) is allowed to range
from 5% to 20% of the population size. The population of Allegheny County, PA is about
1.2 millions, so the experimental value of (V6) is set as: 60,000, 80,000, 100,000, 150,000,
200,000, and 250,000.
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(V7) vaccine additional per day: This variable represents the additional daily supply
of vaccines. It is required that (V7) is less than or equal to (V6). Starting from the first
day of the simulated influenza season, an additional amount of (V7) will be made available
on each day until the total planned vaccine supply (V6) has been reached. Given (V6), the
variable (V7) largely determines the vaccine availability over time. We allow (V7) to take
the following values: 1,000, 2,000, 4,000, 6,000, 8,000, and 10,000 subject to the constraint
(V7) ≤ (V6).
2.4.2 Antiviral
Antiviral drugs are a class of medication used specifically for treating viral infections, and
hence antiviral policies are for treatment as opposed to prevention of the disease. In an
influenza epidemic, the availability of antiviral drugs is a major concern, besides the ef-
fectiveness of the drugs[13]. The following four variables are used to specify an antiviral
policy.
(A1) enable antivirals: It is a Boolean variable, which can be either 0 or 1. A value
of 0 corresponds to no implementation of antiviral strategies at all; and when (A1) is equal
to 0, the variables (A2)-(A4) play no part in the simulation model. When (A1) takes a value
of 1, the variables (A2)-(A4) come into play and their settings specify an antiviral strategy
to be implemented.
(A2) av total avail: It is the total amount of antiviral doses that will be made available
in the epidemic season. A range of values have been selected for (A2): 10,000, 50,000,
100,000, 200,000, 300,000 and 400,000.
(A3) av initial stock: It is the initial stock of antivirals with healthcare agencies and
hospitals at the beginning of epidemic season. The experimental values of (A3) are set as:
1,000, 5,000, 10,000, 20,000, 30,000, and 40, 000, with (A3) ≤ (A2).
(A4) av additional per day: It is the daily antiviral doses added to supply, from the
first day of the influenza season until the total planned amount (A2) has been reached. In
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this work, the variable (A4) is allowed to be 1,000, 5,000, 10,000, 20,000, 30,000 and 40,000,
subjecting to the constraint: (A3)+(A4) ≤(A2).
2.4.3 School Closure
As an indirect intervention strategy, school closure has been debated and questioned [14, 15,
16]. It has been noted that school closure could be very costly and perhaps not worthwhile,
whereas at the same time, transmission among school children is also considered to be
a primary mode of disease propagation[8, 1]). In this work, four decision variables are
associated with school closure policies.
(S1) school closure policy: This variable is used to set the type of school closure
policy, and it can be any of the three categories: none, global, and individual. When (S1)
is set as “none”, school closure policy is disabled, and the variables (S2)-(S4) play no part
in the simulation model. When (S1) is set as “global”, the global school closure policy is
adopted and specified by the variables (S2) and (S4) below. When (S1) is set as “individual”,
the individual school closure policy is employed and specified by the variables (S2), (S3) and
(S4), as will be seen.
(S2) school closure threshold: When the global school closure policy is employed,
(S2) is the threshold attack rate (defined later in Section2.5), above which all schools are to
be closed. In Lee et al[2], a threshold of 1% is used, which means closure of all schools once
the attack rate of the population being considered exceeds 1%. Herein, we allow (S2) to vary
over the range of [0.5%, 1.5%], and take the following values: 0.5%, 0.7%, 0.9%, 1.1%, 1.3%,
and 1.5%.
(S3) school closure cases: Under the individual school closure policy, a school will be
closed if the number of infection cases at that individual school reaches the threshold (S3)
or the global attack rate reaches threshold (S2). As in Brown et al[4], (S3) is set to range
from 1 to 30, with experimental values: 1, 5, 10, 15, 20, 25, and 30.
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(S4) Weeks: It is the duration of school closure once a closure has been triggered.
Following Brown et al[4], (S4) ranges within [1, 8] weeks, and takes the following values in
our work: 1, 2, 4, 6, and 8 weeks.
2.5 Performance Metrics
We have extended FRED to evaluate the five most commonly-used performance metrics
[17, 11, 18, 19] for each scenario specified by a combination of the intervention policies (i.e.,
a setting of the decision variables). These performance metrics are described as follows.
1. ATTACK RATE (AR): An attack rate is the proportion of a well-defined population
that develops illness over a specific period of time[20], where the numerator is the
number of new cases that occurred during that period and the denominator is the
size of the population at risk (i.e., the individuals with a probability of acquiring the
disease in the area considered). Attack rate is an important indicator used to aid in
marshalling resources for delivery of medical care as well as production of vaccines
and/or anti-viral and anti-bacterial medicines[21].
2. DEATHS: Deaths is the outcome indicator that counts the number of deaths during
an epidemic. Since deaths news tends to have severe mental and psychological effects
on people, which may lead to psychological panic and even social chaos, the number
of deaths is always one of primary indicators for epidemic severity[11]. A disease-
associated death results in substantial social and economic losses.
3. INFECTIONS: The total number of infections in an epidemic is the major factor that
determines the medical cost and productivity loss[11].
4. YEARS OF LIFE LOST (YLL): YLL measures the total number of life years lost due
to premature death[11]. The definition of premature death varies in studies, and in
this work, YLL are calculated following the 2008 US Life Expectancy data[22]. YLL
measures health loss from early death, taking into account the age that death occurred.
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 Figure 2.2: The Breakdown of Total Cost.
5. TOTAL COST (TC): The total cost seeks to quantify the economic and social losses
incurred in an epidemic. Figure 2.2 illustrates the breakdown of the total cost, which
can be divided into two parts: the intervention cost, and the infection cost. (i) The
intervention cost includes the cost to implement the intervention policies: the manufac-
turing and delivery cost of vaccines/antivirals, the cost accounting for the productivity
loss of teachers, and school students missed cost (including student daily cost and
parents productivity loss due to missing work), etc. (ii) The infection cost includes
the cost triggered by disease infections, for which we distinguish two types of infected
populations: the asymptomatic population that does not incur any infection cost yet
(while being at increased risk for becoming symptomatic), and the symptomatic pop-
ulation. The cost incurred by symptomatically infected individuals is divided into two
categories: death cost, and non-death cost caused by inpatients, outpatients and those
who only need over-the-counter drugs. In each category, a patient incurs a cost of
treatment depending on his/her age, vaccine condition, and a cost of productivity loss
due to absenteeism. The cost parameters are given in Table 2.1.
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Table 2.1: Cost Parameters.
Cost Values
Vaccination cost (per dose) $37.26
Antiviral cost(per course) $134.30
Medical cost(per death)
age 0-19 $3435
age 20-64 $7605
age 65+ $8309
PV earning lost (per death)
age 0-19 $1016101
age 20-64 $1037673
age 65+ $65837
Non-death cost (per infection)(vaccinated)
age 0-19 $309.24
age 20-64 $377.42
age 65+ $517.46
Non-death cost(per infection)(unvaccinated)
age 0-19 $330.28
age 20-64 $418.02
age 65+ $557.97
Teacher productivity loss (per teacher per day)(2009 US Dollars) $208
Student school missed cost
$19.22
(per student per day)(2009 US Dollars)
2.6 Objective function
The ultimate goal is to find the intervention policies that lead to the best performance
while minimizing the total cost involved.The objective function is formulated as: “Minimize
both AR and TC with respect to the intervention policies specified by the decision variables
(V1)-(V7), (A1)-(A4), (S1)-(S4).”
Since the first four performance metrics: AR, DEATHS, INFECTIONS and YLL
are correlated with each other while emphasizing different aspects of epidemic severity, and
since AR is most-widely used in the existing literature, we consider AR as the performance
objective of the optimization. The cost objective is of course to minimize the total cost
incurred for the epidemic. Hence, the objective function is generated.
With the decision variables (along with their possible settings) presented in Section
2.4, there are totally 10,459,400 scenarios of different intervention policies. It takes about 3
minutes to complete a single simulation run by a 16-core Dell workstation. In light of the
13
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Figure 2.3: The GA Workflow.
computational burden, a GA algorithm is adapted to search for the Pareto frontier of the
multi-objective optimization problem.
2.7 GA application
The GA framework is given in Figure 2.3. A brief overview of Genetic Algorithm is provided
below. It starts with the random generation of an initial population of candidate policies.
The population size is, say 60. For each candidate in the current population, simulation
experiments are carried out to evaluate the performance and cost associated with that can-
didate; NCi (i = 1, 2, . . . , 60) simulation replications are obtained for each candidate policy
using different random streams; and the simulation length of each replication is 180 days.
Here, both optimization objectives are to be minimized. Following the fitness evaluation, a
tournament selection, crossover and mutation are carried out to produce a new population
of candidates for further evaluation and reproduction.
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2.7.1 Genetic Encoding
At the beginning of Genetic Algorithm, we need to encode a string of genes which can be
considered as chromosomes in the organism. In general, there are three encoding methods:
a fixed length binary values (0,1), Arabic numbers (1,2,3,...) and alphabetical characters
(A,B,C,...). In this study, the genes are encoded by 13-digit Arabic numbers. The 1st to
5th,6th to 9th,and 10th to 13th genes represent Vaccine strategy, Antiviral strategy, and
School Closure strategy respectively.
In Figure 2.4, the first row represents the value of each digit. The first column denotes
the location of the digit. The second column represents the corresponding decision variable.
The blank in the table implies that for a certain digit, it cannot take that value. For example,
the value “6,000” in row 6, column 6 means that if the value of 5th digit in a string is equal
to 3, the value of variable ”V7” is equal to 6000. Figure 2.5 gives an example of a string of
genes.
As shown in Figure 2.1, with the experimental settings in Section 2.4, there is a total
of 216 candidate vaccination policies, 199 candidate antiviral policies, and 240 candidate
school-closure policies. A policy combination of the three intervention strategies is encoded
as a 13-digit genetic string in the GA.
2.7.2 Fitness Calculation
An initial population containing 60 individuals should be first generated. Each individual is
a random 13-digit string corresponding to a strategy combination. Feeding each of the 60
policies into FRED leads to the corresponding performance metrics of these policies.
Fitness evaluation is performed by using the Pareto-ranking method proposed by
Goldberg [23]. The Pareto-ranking method explicitly utilizes the Pareto dominance rule to
rank candidates, and assigns a fitness value to each candidate based on its ranking in the
current population. To determine the rank, individuals in the population are considered as
points which have two dimensions: Attack Rate as x-axis and Total Cost as y-axis. The
15
Value 0 1 2 3 4 5 6
1st digit V1 0 1
2nd digit V2,V3 (1,0) (0,1)
3rd digit V4,V5 (0,5) (6,24) (25,44) (45,64) -65,120
4th digit V6 60,000 80,000 100,000 150,000 200,000 250,000
5th digit V7 1,000 2,000 4,000 6,000 8,000 10,000
6th digit A1 0 1
7th digit A2 10,000 50,000 100,000 200,000 300,000 400,000
8th digit A3 1,000 5,000 10,000 20,000 30,000 40,000
9th digit A4 1,000 5,000 10,000 20,000 30,000 40,000
10th digit S1 Inividual Global
11th digit S2 0.5 0.7 0.9 1.1 1.3 1.5
12th digit S3 1 5 10 15 20 25 30
13th digit S4 1 2 4 6 8
Figure 2.4: The Meaning of each digit.
1 1 2 3 5 1 2 0 1 0 2 4 2
V1=1
(V2,V3)=(0,1) 
(V4,V5)=(25,44)
V6=150,000
V7=10,000
A1=1
A2=100,000
A3=1,000
A4=5,000
S1="Individual"
S2=0.9
S3=20
S4=4
Vaccination Strategy Antivirals Strategy School Closure
Figure 2.5: Genes Encoding
points(individuals) which are closest to x-axis and y-axis at the same time among the whole
population have rank one. Remove these points, and then find the set of points with rank
two following the same scheme. Repeat this Pareto-ranking method and obtain the ranks of
all the individuals in the current population.
2.7.3 Selection
Based on the fitness list, 60 individuals are chosen as parents to generate offsprings by
tournament selection. Tournament selection involves running several “tournaments” among
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Figure 2.6: Tournament Selection
a few individuals chosen at random from the population. The winner of each tournament
(the one with the best fitness) is selected as parent(Figure2.6). One of the most important
factors to affect the result of tournament selection is tournament size. If the tournament size
is large, weak individuals will have a small chance to be selected, but it is easier to fall into
local optimum. In this study, a range of tournament sizes have been tested and it is finally
set as one tenth of the population size.
2.7.4 Crossover and Mutation
Crossover operator for the chromosome is based upon the two-point crossover scheme. Two
breakpoints are generated randomly, then the genes between two breakpoints are switched
to generate two children (Figure 2.7).
Crossover leads to a fixed number of genes to be mutated. The mutation rate is
recommended to be five percent[24] of the total number of genes in the whole population.
There are two commonly-used mutation methods. One is to add 1 or -1 to the selected gene.
The other is to generate a random number and to replace the selected gene by that number.
In my study, the second method is applied.
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1 1 2 3 5 1 2 0 1 0 2 4 2
1 1 0 2 4 1 5 1 3 0 4 5 4
Parent 1
Parent 2
1 1 2 3 4 1 5 1 1 0 2 4 2
1 1 0 2 5 1 2 0 3 0 4 5 4
Child 2
Child 2
Figure 2.7: Crossover Operator
The GA algorithm was implemented in Python, and integrated with the simulation
model in C++ programming language. For each candidate solution generated by GA in
Python, the corresponding parameter settings are written in a text file, which serves as
input to the simulation model in C++; and the simulation results are sent back to the GA
in a text file as well.
2.8 Determine the number of replications
For a candidate solution in the optimization search, multiple simulation replications are
carried out to estimate its performance metrics. The number of replications, NCi , required for
each candidate ,{Ci;i = 1, 2, ..., 60}, which corresponds to the ith candidate in a generation,
to obtain estimates of E[AR(Ci)] and E[TC(Ci)]. Denote a performance metric as M(Ci) in
general, where M(Ci) can be AR(Ci) or TC(Ci). The two-stage method[25, 26] is utilized
to determine the number of replications N so that a desired precision can be achieved for
Eˆ[M(Ci)].
Ŝtd[M(Ci)]
Eˆ[M(Ci)]
< γ% (2.1)
where Ŝtd[Eˆ[M(Ci)]] is the estimated standard deviation of Eˆ[M(Ci)], and γ% the target
precision level. At the first stage, an initial number of replications N0 are generated. Denote
Eˆ[M(Ci)] as the estimated mean of M(Ci) and Ŝtd0[Eˆ0[M(Ci)]] as the estimated standard
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deviation of Eˆ0[M(Ci)]] from the N0 replications. Then the number of replications N that
is likely to achieve the target presicion level γ% is estimated as
NCi = d
Ŝtd0[M(Ci)]
Eˆ0[M(Ci)]× γ%
e (2.2)
At the second state, NCi − N0 additional replications are generated and the data collected
at both stages are used to estimate the performance metrics.
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Chapter 3
Results and Discussions
Since the objective function has two dimensions: AR and Total Cost, we use Pareto
frontier to find a good solution in a set of points. Pareto frontier is a set of points where it is
impossible to make any one objective value better off without making at least one objective
value worse. In other words, there is no other point that can be closer to X-axis and Y-axis
at same time than the Pareto frontier.
In the GA-based simulation optimization, 1470 candidate policies were evaluated, and
their corresponding objective values, AR and Total Cost, are represented as dots in Figure
3.1. The dotted curve depicts the Pareto frontier of solutions, and a total of 8 intervention
policies lie on the frontier. For each Pareto solution/policy, its pair of AR and school closure
cost is plotted as square in Figure 3.2. In addition, the (AR, vaccination cost) pair is
depicted as a cross, the (AR, antiviral cost) as a time symbol, the (AR, non-death infection
cost) as diamond, and (AR, death infetion cost) as star; the vaccination and antiviral costs
are very low compared to the school closure cost, and the squares and crosses both lie along
the bottom of Figure 3.2. For example, the three Pareto solutions/policies (marked as Pu,
Pm and Pd in Figure 3.1) are given in Table 3.1, and their five performance metrics are
also provided. As can be seen from Table 3.1, AR is positively correlated with DEATHS,
INFECTIONS, and YLL. The simulation optimization results support the following findings.
• Vaccination
This study confirms that vaccination has significant impact on mitigating a H1N1 epi-
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Figure 3.1: Solutions Resulting from the Simulation Optimization.
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Figure 3.2: Pareto Frontier and its Cost.
demic. All the policies included in the Pareto frontier call for a maximum total quantity
of available vaccines by setting (V6) vaccine total avail at its maximum 250,000.
When vaccine supply is relatively plentiful (with the available vaccine quantity being
more than 20% of the population as in these Pareto solutions), the age-based vaccine
prioritization (with the priority group being the one from 0 to 5 years of age) is favored
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Table 3.1: Three Selected Pareto Policies.
Pareto
Policies
Decision Variables
Outcomes
AR(%) Deaths Infections YLL Total Cost($)
Pu
V1=1,V2=0,V3=1,V4=0,
15.738 38 191,809 1,598 624,723,461
V5=5,V6=250000,
V7=10000,
A1=1,A2=400000,
A3=10000,A4=30000,
S1=individual,S2=0.5,
S3=25,S4=8
Pm
V1=1,V2=0,V3=1,V4=25,
24.534 61 298,991 2,412 407,195,582
V5=44,V6=250000,
V7=10000,
A1=1,A2=400000,
A3=40000,A4=40000,
S1=individual,S2=1.5,
S3=10,S4=1
Pd
V1=1,V2=0,V3=1,V4=65,
30.993 74 377,725 3,073 258,321,080
V5=120,V6=250000,
V7=10000,
A1=1,A2=400000,
A3=10000,A4=10000,
S1=individual,S2=1.5,
S3=1,S4=2
over the ACIP recommendation. This complements the findings of Lee et al[3]: the
ACIP prioritization should be adhered to when vaccine is in limited supply. By ex-
amining the GA candidate solutions with the minimum vaccine supply (with available
vaccine quantity being 5% of the population), we also confirmed the superiority of
ACIP in term of vaccine scarcity.
• School closure
The cost and benefits of school closure are reflected in Figure 3.1. Compared to vacci-
nation and antiviral strategies, the cost of school closure is very high, which is a cause
for debate whether school closure is worthwhile[4].
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All the Pareto solutions adopt the individual school closure policy, which is consistent
with the CDC recommendation[27] that school closures should be implemented at
the discretion of local authorities based on local considerations. Lee et al. (2010)[2]
was not able to show any significant differences between individual and global closure
policies, at least partly because that in their work, the impacts of different school
closure policies were evaluated with all the other intervention policies fixed at certain
levels, levels different from those in our Pareto solutions.
The individual school closure policies involved in these Pareto solutions vary in terms
of their thresholds for closure (i.e., the values for the variable (S3) school closure cases)
and their closure periods (i.e., the values for the variable (S4) Week). As illustrated
in Table 3.1, the Pareto solutions are similar in terms of the vaccination and antiviral
treatment policies. Hence, the times symbols in Figure 3.1 for school closure cost vs.
AR indicates: The individual closure parameters, (S3) school closure cases and (S4)
Week, affect both the school closure cost and the AR performance. This finding is again
not given by Lee et al[3], who claim that AR is not sensitive to such variables. The
trade-offs between cost and benefits are displayed in Figure 3.1, and can be employed
for decision making regarding school closures.
• Antiviral Policies
For each of the Pareto solutions, a large quantity of antiviral drugs is utilized with the
variable (A2) av total avail being in its highest allowed value. As vaccination, antiviral
strategies are relatively cost-effective, and hence tend to be pushed to its upper limit
in the optimization iteration.
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Chapter 4
Summary and Future Research
A GA-based simulation optimization method was employed to explore the large de-
cision space spanned by the decision variables for three types of intervention strategies:
vaccination, antiviral treatment, and school closure. Our investigation suggests that differ-
ent vaccine prioritization strategies be implemented depending on the vaccine availability:
Age-based priority (with the group from 6 to 24 years of age being the priority group) is fa-
vored when vaccine supply is plentiful; and the ACIP is preferred in time of vaccine shortage.
As far as school closure strategies are concerned, individual school closure policies appear
to work better than their global counterparts, at least when both vaccination and antiviral
treatment are both implemented with relatively plentiful medicine supply. In addition, the
threshold and duration variables used to specify an individual closure policy tend to affect
its cost and resulting benefits, the trade-offs of which have been graphically illustrated and
can be used to support decision making.
Simulation-based optimization could be extremely time-consuming, and hence does
not support real-time decision making. In the future work, metamodeling approach will be
investigated to build a metamodel relating the performance metrics to the various decision
variables. A metamodel is expected to have the high-fidelity of simulation as well as to
allow for real-time “what if” analysis. Metamodel-based optimization will be substantially
faster than its simulation-based counterparts, and thus has to potential to assist in real-time
decision making.
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